KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsR&D In ProcessShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Issued (2016 - 2020)

Historic Shares Issued for Pfizer (PFE) over the last 9 years, with Q3 2020 value amounting to $206.0 million.

  • Pfizer's Shares Issued rose 27454.55% to $206.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $455.0 million, marking a year-over-year decrease of 172.79%. This contributed to the annual value of $425.0 million for FY2020, which is 786.8% up from last year.
  • Pfizer's Shares Issued amounted to $206.0 million in Q3 2020, which was up 27454.55% from $34.0 million recorded in Q2 2020.
  • Pfizer's Shares Issued's 5-year high stood at $625.0 million during Q3 2018, with a 5-year trough of $34.0 million in Q2 2020.
  • Moreover, its 5-year median value for Shares Issued was $160.0 million (2018), whereas its average is $205.2 million.
  • Per our database at Business Quant, Pfizer's Shares Issued tumbled by 9120.0% in 2019 and then soared by 27454.55% in 2020.
  • Over the past 5 years, Pfizer's Shares Issued (Quarter) stood at $73.0 million in 2016, then surged by 182.19% to $206.0 million in 2017, then fell by 22.33% to $160.0 million in 2018, then crashed by 43.12% to $91.0 million in 2019, then surged by 126.37% to $206.0 million in 2020.
  • Its last three reported values are $206.0 million in Q3 2020, $34.0 million for Q2 2020, and $124.0 million during Q1 2020.